Reuven Bergman
- 5 Excellent • 2 reviews
- Israel, Haifa, Rambam Medical Center
- Oncodermatologist
Education
Sep 2009 – Jun 2014 Medical Degree - Doctor of Medicine and Surgery (MD)
University of Malta
Sep 2006 – Jun 2009 Bachelor of Science in Pharmaceutical Sciences (BSc Honours)
University of East Anglia (United Kingdom)
Work Experience and Training
Aug 2021 – Aug 2022 Senior Skin Cancer Fellow
St John’s Institute of Dermatology, Guy’s and St Thomas’ hospitals
King’s College London, UK
Sep 2017 – Sep 2020 Dermatology and Venerology Specialty Trainee
Sheba Medical Centre, Tel-Hashomer
Tel-Aviv, Israel
Sep 2016 – Aug 2017 Senior House Officer in Ortho-Geriatrics
Colchester University Hospital, NHS Foundation trust
Aug 2015 – Aug 2016 Year 2 Doctor
NHS Greater Glasgow and Clyde
Rotations in the following specialties:
General Medicine, Obstetrics and Gynaecology, Trauma & Orthopaedics
Aug 2014 – Aug 2015 Year 1 Doctor
NHS Greater Glasgow and Clyde
Rotations in the following specialties:
General Medicine, General Surgery (skin cancer clinics and minor ops)
Other activity
May 2022 British Society of Skin Care in Immunosuppressed Individuals
Update on skin diseases in immunosuppressed - London
Oct 2021 British society of dermatological surgery course – London
Sep 2021 St John’s Academy dermoscopy course - London
Dec 2019 International nail disorders conference – Tel-Aviv
Sep 2019 Annual Dermoscopy course – Tel-Aviv
Sep 2018 27th EADV congress - Paris
Feb 2016 Basic Surgical Skills course
Royal College of Surgeons of Edinburgh (RCSEd)
Aug 2015 Training the Clinical Teacher Diploma
University College London (UCL)
Sep 2013 Head and neck flap course - NHS Oxford Deanery
Memberships and Registration
Key International Publication
Kim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.
“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”
Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.
International Conference Presentations
The International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, Korea
The 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, Thailand
Domestic Conference Presentations
The Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, Korea
The 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, Korea
The 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, Korea
The 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, Korea
The Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea
Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.
Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.
Oncologist
Transplantologist
Specialist in Oncodermatology
Oncologist, dermatologist
Dr. Chaitainya Borde is a nuclear medicine specialist with 12 years of clinical experience. He is skilled in advanced nuclear scans, PET-CT imaging, and nuclear cardiology. He works in both diagnostic and therapeutic nuclear medicine.
Dr. Borde has performed over 30,000 PET scans. He has managed more than 1,000 thyroid cancer patients. He is experienced in radioiodine and Lu-177 RN therapies. He has also published research papers in respected medical journals, showing his dedication to academic work.
Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.
Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.